Neisseria meningitidis is a cause of fatal sepsis and epidemic meningitis. A major virulence factor is cell wall lipooligosaccharide (LOS). The M986 strain has been used extensively in immunological and vaccine research. Yet, the LOS repertoire of this strain is not known. Here we have investigated the LOS structures of M986 and three of its variants OP1, OP2؊, and OP2؉. This strain and its variants present a series of related LOS families that are increasingly truncated in their listed order. The major structural differences are seen in the lacto-N-neotetraose ␣-chain. The ␥-chain Hep II contains two phosphoethanolamine (PEA) substitutions at C3 and C6/7. These substitutions were seen in all strains except OP2؉ where the canonical core Hep II is missing. The PEA disubstitution was present in nearly stoichiometric amounts with only minor amounts of monosubstitution observed, and no glycomers devoid of PEA were seen. This was also the case in LOS with a complete lacto-N-neotetraosyl ␣-chain even though previous reports suggested that the presence of an extended ␣-chain hinders C3 PEA substitution of Hep II. Approximately 50% of ␥-chain GlcNAc was present in its 3-OAc-substituted form. Because Hep II C3 PEA substitution and ␥-chain GlcNAc OAc addition have been reported to negatively interact, the co-existence of these two modifications in these strains is unique. The LOS structures of M986 and three of its variants have been determined, which better defines these strains as tools for immunological and vaccine research.
Neisseria meningitidis is a causative agent in fatal sepsis and epidemic meningitis. The structure and composition of cell wall lipid oligosaccharide (LOS) 2 can vary markedly from strain to strain as the result of phase variation, which allows immune system avoidance leading to infection. N. meningitidis LOS can be serologically divided into 12 immunotypes (L1-12) (1). The LOS structures for L1/6 (2), L2 (3), L3 (4), L4/7 (5), L5 (6) , and L9 (7) have been reported, and those for L10/11 have been partially resolved (8) . However, novel LOS structures continue to be reported.
N. meningitidis LOS has a conserved core composed of Glc 1 Hep 2 KDO 2 -Lipid A. Structural motifs observed in N. meningitidis LOS are shown in Scheme 1. Emanating from this conserved core are ␣-, ␤-, and ␥-chains, and structural variation can be imparted to the LOS in these regions. There are two alternative ␣-chains, which include lacto-N-neotetraose (LNT) and globobiose. Both can be capped with NeuAc as seen in immunotypes L2 (3), L3 (4), L4 (5) , and L5 (6) . Abbreviated forms of LNT have also been seen as the major LOS in some strains such as L6 (2) . The ␤-chain extends from the C3 of the core Hep II residue, and in N. meningitidis this extension is limited to addition of Glc␣1,3-(6). The ␥-chain consists of a GlcNAc␣1,2-from the core Hep II. It can be present in 3-Oacetylated or unacetylated forms (9) . Acetylation of ␥-chain GlcNAc has been reported in L1, L2, L4, L5, and L6 strains (2, 3, 5, 6) . Hep II can be considered a hub of structural diversity. Along with Glc␣1,3-substitution, it can also be C7-substituted with Gly (3, 10) , and C3, C6, and C7 can be substituted with phosphoethanolamine (PEA). The genes encoding the phosphoethanolaminyltransferases, Lpt3 and Lpt6, have been isolated (11) (12) (13) . Lpt3 is required for addition of the C3 PEA of Hep II (12) . Inactivation of Lpt6 prevents addition of both C6 and C7 addition of PEA to Hep II, and therefore it has been concluded that lpt6 catalyzes the addition of both additions (9) . No other phosphoethanolaminyltransferase homologue has been detected in Neisseria. The presence of PEA-disubstituted Hep II is rare and has only been reported in strains with a truncated ␣-chain (11, 14) . It has been speculated that, in the absence of the ␣-chain phosphoethanolaminyltransferases Lpt3 and Ltp6 have greater access to the core Hep II, and this was likely the reason for the enhanced substitution.
There is considerable interest in Neisseria LOS in vaccine design and development. Hep II C3 PEA has been shown to bind complement C4b. Antibodies that bind this motif are bactericidal and have been shown to facilitate opsonophagocytosis (15) (16) (17) . Monoclonal antibodies to this motif have been shown to provide passive immunity against some strains. Strains with LOS containing the 3Ј-PEA of Hep II and an ␣-chain LNT or those with the sialo-LNT form tend not to produce antibodies with bactericidal activity. This result has led researchers to speculate that the ␣-chain somehow shields the 3Ј-PEA Hep II region from immune recognition and processing. However, antibodies raised against the inner core can provide passive immunity. A monoclonal antibody raised to the LOS of a galE, an ␣-chain-deficient strain, has been shown to provide passive protection in mice against a number of N. meningitidis strains (18) . Certainly, additional strains with truncated ␣-chain and core Hep II PEA substitution could be of value for vaccine research.
N. meningitidis strain M986 was clinically isolated in 1967 (18) . This strain and its variants have been used extensively in the study of immune system regulation and vaccine development (18 -31) , yet, little is known about its LOS structure. Inoculation of mice with outer membrane vesicles from both encapsulated and non-encapsulated M986 strains has been shown to provide protection against lethal doses of endotoxin and infective doses of live bacteria (19) . These strains have also been used to investigate immune regulatory properties of N. meningitidis (26, 27) and both LOS and outer membrane vesicles enhance granulocyte recovery in myelosuppressed mice (22) .
In this study the LOS structures of a non-encapsulated strain of M986 and three of its variants, selected based on altered colony opacity, were investigated. M986 LOS reacts strongly with L7, moderately with L4, and has low activity with L2, L3, L6, and L8 antisera (25) . Multiple reactivities across immunotypes suggested that structural motifs from each may be present in M986. The interest in M986 as a tool for immune system and vaccine research warrants a thorough investigation of its LOS structural repertoire and its variants. Here the LOS structures of M986 and three of its variants are reported, and implications of these findings for immunological and vaccine research are discussed.
EXPERIMENTAL PROCEDURES
Strain Designation-It has been noted that a decrease in opacity correlates with changes in LOS structure. Using an opacity designation, as compared with the wild-type strain, a variant can range from a score of Ϫ2 through ϩ2, where the former indicates low opacity and the later indicates a high degree of opacity. These designations were used in isolation of the M986 variants studied here. Therefore, the strains studied here are referred to as M986 OP1ϩ, OP2Ϫ, and OP2ϩ.
Isolation of LOS-LOS samples were isolated from wild-type and mutant strains grown in Catlin medium (32) by the hot phenol/water extraction procedure (33, 34) . The samples were extracted with phenol/water again, and the LOS in the aqueous phase was precipitated by the addition of 2 volumes acetone, and washed twice with 95% ethanol. Analysis of LOS by SDS-PAGE, silver staining, and Western blotting was performed as described previously (35) . Meningococcal mouse monoclonal antibody 9-2-L3,7 for Western blotting was a generous gift from Dr. W. D. Zollinger of the Walter Reed Army Institute of Research, Washington, D. C., and its binding specificity with LOS immunotypes has been described elsewhere (1) .
Chemical Methods-LOS was deacylated by hydrazinolysis as previously described (36) . Approximately 5 mg of LOS was placed in a 25-ml glass centrifuge tube, and 1.1 ml of anhydrous hydrazine was added. The sample was placed in a water bath at 37°C for 20 min with occasional sonication. The sample was then cooled to Ϫ20°C, and 5.5 ml of cold acetone was added dropwise. The precipitated deacylated LOS was recovered by centrifugation at 12,000 ϫ g for 20 min. The supernatant was removed, and the pellet was washed once again with acetone. The deacylated LOS pellet was dried and resuspended in 0.5 ml of distilled H 2 O. To yield the free oligosaccharide LOS was subjected to mild acid hydrolysis. 1-1.5 mg of LOS was dried and resuspended in 300 l of 2 M acetic acid, and then incubated at 80°C for 3 h. The hydrolysate was then dried in a Savant vacuum centrifuge and resuspended in 1% butanol.
Mass Spectrometry-MALDI-TOF MS analysis was performed on a Perseptive Biosystems Voyager DE RP mass spectrometer. Spectra were collected in linear negative ion mode. Approximately 100 to 150 shots from the 337 nm laser were collected and summed. Laser pulses were 3 ns in length. Spectra were calibrated externally using a maltooligosaccharide ladder. Ion-trap MS was performed on a ThermoFinnigan LCQ deca mass spectrometer equipped with a electrospray ion source. The following mass spectrometer parameters were used: capillary temperature, 170°C; ion spray voltage, 3.5 Kv. Normalized collision energies were set between 25 and 30%, and an isolation width of 2 amu was used. Sheath gas was used. Solvent was 50% acetonitrile with 0.1% formic acid. LC/MS experiments were collected on the same instrument in line with a ThermoQuest Surveyor LC system equipped with a Tosch Biosystems TSK Amide-80 column (1 ϫ 150 mm, 5 ). Solvent A was 70% acetonitrile, 5 mM NH 4 OAc. Solvent B was 2% acetonitrile, 5 mM NH 4 OAc. The gradient was as follows: 5% solvent A for 5 min, 5-70% solvent A over 30 min, hold at 70% solvent A for 5 min, followed by re-equilibration at 5% solvent A for 20 min. Samples consumed in analyses were ϳ3-4 g.
High Field NMR-High field 1 H NMR experiments were conducted on a 300-MHz Bruker NMR instrument. The one-dimensional experiments were collected at 298 K over 3002 Hz using 16,000 points of digitization. Samples were externally referenced to tetramethylsilane (TMS) using an internal standard of acetone at 2.225 ppm. Either 512 or 1,000 scans were collected for each sample depending on abundance of sample material.
Monosaccharide Analysis-LOS samples in water (1 mg/ml) were treated with 1% acetic acid at 100°C for 2 h to generate oligosaccharides, lipid A, and KDO by splitting labile KDO linkages. Lipid A was removed by ultracentrifugation at 350,000 ϫ g for 1 h using a Beckman Optima TXL tabletop ultracentrifuge. The supernatants were lyophilized to remove acetic acid. This residue containing oligosaccharide and free KDO were reconstituted with water to original volumes. For hexose and amino sugar analyses, oligosaccharide samples were hydrolyzed at 100°C for 6 h in 2 N trifluoroacetic acid and 4 N HCl, respectively (37) . After removal of trifluoroacetic acid or HCl by SpeedVac, the samples were dissolved in water. Unhydrolyzed oligosaccharide samples were used for KDO analysis.
Monosaccharides in the samples were analyzed using a highperformance anion-exchange chromatography with pulsed amperometric detection, a Dionex ICS3000 HPLC system (Sunnyvale, CA) with a CarboPak PA1 column, an ED40 detector, and Chromeleon software. The monosaccharides in samples were eluted off the column using a combination of 11 mM NaOH (A) and 1 M sodium acetate with 200 mM NaOH (B) at a flow rate of 1 ml/min. The eluting program consisted of an isocratic 11 mM NaOH (100%) for 15 min and then a gradient generated by of 65% A and 35% B at 35 min using curve 9 of the Chromeleon software. The column was washed with B for next 5 min (curve 8) followed by 200 mM NaOH for 3 min and reequilibrated with 11 mM NaOH for 12 min for each run. The monosaccharides in the column eluent were monitored by using the ED40 detector with pulsed amperometric detection. A five-sugar mixture of glucosamine, galactose, glucose, L-glycero-D-mannoheptose (heptose), and KDO had the retention times of 12.5, 14.7, 16.3, 28.4, and 38.6 min, respectively.
Linkage Analysis-For glycosyl linkage analysis, the samples were permethylated, hydrofluoric acid-treated, ethylated, depolymerized, reduced, and acetylated, and the resultant partially methylated and partially ethylated alditol acetates were analyzed by gas chromatography-mass spectrometry (GC/MS) as previously described (11) .
Initially, an aliquot of sample was permethylated using a slightly modified version of Ciucanu and Kerek (38) . The samples were then loaded onto Waters C18 Sep Paks, which were rinsed with water and 15% acetonitrile, followed by sample elution with acetonitrile followed by isopropanol. Material was then dried in Teflon test tubes and treated with 200 l of 48% hydrofluoric acid overnight. After drying, samples were suspended in DMSO and allowed to incubate over 96 h at room temperature to promote dissolution. Samples were then ethylated using the Ciucanu procedure described above but replacing methyl iodide with ethyl iodide followed by extraction of the samples into dichloromethane. The material was hydrolyzed using 2 M trifluoroacetic acid (2 h in sealed tube at 121°C), reduced with NaB 2 H 4 , and acetylated using acetic anhydride/trifluoroacetic acid. The resulting partially methylated partially ethylated alditol acetates were analyzed on a Hewlett-Packard 5890 GC interfaced to a 5970 MSD massselective detector operated in electron impact ionization mode. Separation was performed on a 30-meter Supelco 2330 bonded phase fused silica capillary column.
RESULTS

Structural Analysis: Rational and Summary-O-Deacylated
LOS from each strain was analyzed by MALDI-TOF MS to reveal compositional and structural features of the deacylated lipid A. O-Deacylated Lipid A discussed in the following sections will be referred to as Lipid A for the purposes of brevity. More structural detail was revealed by analysis of lipid released oligosaccharide (OS) by ion-trap MS and tandem MS experiments with and without LC/MS interface. Monosaccharide analysis was also performed, and linkage configuration was confirmed by high field NMR analysis. To verify positional information concerning PEA residues, GC/MS analysis of the partially methylated partially ethylated alditol acetates was performed.
Results show that M986 LOS is unique in terms of its overall structure. Structural characteristics include an LNT ␣-chain, 3,6/7-diphosphoethanolaminyl heptose, and a ␥-chain consisting of GlcNAc␣1,2-linked to Hep II where 50% of that GlcNAc is O-acetylated at C3. Truncated forms of the full-length LOS are fairly abundant in the M986 parent. Opacity variants OP1, OP2Ϫ, and OP2ϩ are increasingly truncated in the listed order. OP1 LOS was missing terminal ␣-chain Gal␤1,4-. OP2Ϫ LOS was missing ␣-chain Gal␤1,4GlcNAc␤1,3-. OP2ϩ LOS was severely truncated and contained only core KDO residue and Hep I of the core.
It should be noted that fragmentation data were collected for all ions listed in Table 1 , and common ions across the parent and variant strains produced nearly identical spectra supporting the notion that the strains produce the same general structures albeit with increasing amounts of truncation as described previously. Monosaccharide data of the intact LOS confirmed the components in each strain to be either canonical or truncated forms of the canonical LOS. The structural arguments leading to these structural assignments appear below.
Structural Assignment of M986 LOS-Hydrazine-deacylated LOS was examined by MALDI-TOF MS in linear negative mode (Fig. 1A) . Each LOS was typically detected as a series of sodium-adducted molecular ions. Major peaks from LOS derived from M986 were present at m/z 2387. 4 the KDO proximal to the Lipid A is broken. KDO II is lost as its glycosidic bond is labile under releasing conditions. The released OSs were then examined by LC/MS as described under "Experimental Procedures." In some instances offline MS OS interrogation was performed. MS spectra produced from OS that eluted between 12 and 30 min were summed and are shown in Fig. 2A . The detected peaks and their assigned compositions are shown in Table 2 . The compositions detected were consistent with OS predicted from MALDI-TOF MS analyses, but more glycomers were revealed. Truncated forms were observed with compositions consistent with sequential loss of monosaccharides from the ␣-chain, and these were confirmed by tandem MS analysis (data not shown). Additionally, a ϩ42 peak shadowed nearly all major peaks revealing a series of glycoforms with an additional OAc moiety. For instance the Hex 3 HexNAc 2 Hep 2 PEA 2 peak at m/z 1761.4 is flanked by another at m/z 1803.4. The peaks corresponding to added OAc are nearly the same intensity as the main peaks indicating that the glycoforms are likely to be present in nearly the same abundances. All major peaks were consistent with compositions that contained two PEA residues. There were minor species containing one PEA.
The Table 3 . These values were in close agreement with similar structural motifs seen in N. meningitidis LOS (5, 9, 14, 40) . The signals seen at 5.17 and 5.28 ppm show that ␤-chain GlcNAc C3 can be present in both OAc or OD forms, respectively (9) . Hep II H1 is seen at 5.66 ppm, which is downfield of chemical shifts seen in both unsubstituted, C3 Glc-substituted (6), and C3 (4)-or C6 PEA (5)-monosubstituted forms and upfield of it in the C3/C6 PEA-disubstituted form when in the absence of the ␣-chain (9). Therefore, the chemical shift position is consistent with PEA disubstitution as seen by mass spectrometric analysis.
Structural Assignment of OP1 LOS-In MALDI-TOF MS spectra (Fig. 1B) 2 Lipid A. In the later glycolipid additional PEA substitutes Lipid A and will be discussed later. Another peak was seen at m/z 2533.3, which is consistent with the composition Hex 2 HexNAc 2 Hep 2 PEA 3 KDO 1 Lipid A and represents a glycoform with loss of core KDO. Therefore, compared with deacyl LOS from M986, the maximum OP1 LOS is shorter by one hexose. Some forms have one additional PEA and another glycomer, in addition to Hex deficiency, is also shorter by one KDO.
Monosaccharide analysis was performed by high-performance anion-exchange chromatography analysis. Results are shown in Table 1 . Compared with M986 LOS, Gal was significantly lower in molar ratio, which is consistent with the loss of ␣-chain terminal Gal as predicted by MALDI-TOF MS results.
The OS were released from lipid by mild acid treatment and analyzed by ion-trap LC/MS. Ions detected between 12 and 30 min were summed and are shown in Fig. 2B . In comparison to the largest glycomers from M986 those from OP1 are truncated by one Hex residue, which is consistent with MALDI-TOF MS and monosaccharide results. All OS major peaks detected contained two PEA residues. Minor peaks were observed that contained a single PEA residue. As seen in the M986 OS, most major OS peaks were shadowed by a ϩ42 peak indicating that some glycomers contained an additional OAc on ␥-chain GlcNAc. Glycomers that contain only one PEA residue were detected as minor components. The OSs detected in this strain are shown in observed at m/z 366.0, 527.9, and 681.1 (2ϩ), respectively. These data show that the sequence of the ␣-chain was HexNAc-Hex-Hex, which is similar to the largest OS from M986 except that it is truncated at the non-reducing end by one Hex residue. The ␥-chain composition was revealed as HexNAc 1 Hep 2 PEA 2 by the B 2␤ fragment seen at m/z 642.1. As with the same fragment of M986, this ion was isolated and fragmented in MS 3 , which yielded essentially the same pattern as that of M986 (not shown). Thus the PEAs were present on Hep II. 1 H NMR results are shown in Table 3 . H-1 chemical shifts were nearly identical to those of M986 LOS except that Gal␤1,4-was shifted slightly downfield. This was likely due to FEBRUARY 13, 2009 • VOLUME 284 • NUMBER 7
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compared with M986 OP2 -LOS is deficient in GlcNAc and Gal, which is consistent with the MALDI-TOF MS results above and suggests ␣-chain truncation.
OS was analyzed by LC/MS ion-trap analysis. Ions produced between 12 and 30 min were summed and are shown in Table 1 and Fig. 2C . A major OS molecular ion was observed at m/z 1396.2 and was consistent with the composition Hex 2 HexNAc 1 Hep 2 PEA 2 -KDO 1 . A peak was also observed at m/z 1438.2, which is consistent with the same composition with the addition of an acetyl group. The most abundant ions seen were at m/z 1234.4 and 1276.3. These were from OS that is one Hex unit shorter than the related pair seen at m/z 1396.2 and 1438.2. Compared with the largest OS seen in the parent M986 strain the largest saccharides in OP2Ϫ were Hex1HexNAc shorter and the majority of OS was even more truncated, being shorter by Hex2HexNAc. This is consistent with monosaccharide data that showed a loss of GlcN and Gal (see Table 2 ) and MALDI-TOF MS data of the O-deacylated LOS, which showed the same truncation. As seen in M986 and OP1ϩ OS pools, that of OP2Ϫ also had some glycomers with one PEA, although the majority contained two PEA substitutions.
The Hex 2 HexNAc 1 Hep 2 -PEA 2 -KDO 1 , [MϩH] 1ϩ at m/z 1396.2 ion was analyzed by MS 2 . These data are shown in Fig. 3C . Y 2␤ and Y 3␤ fragments were observed at m/z 1072.2 and 1234.2, respectively, and show sequential loss of two Hex residues from the ␣-chain. A B 2␣ fragment was seen at m/z 642.2 and is consistent with the presence of a ␥-chain with the sequence HexNAc-Hep-PEA 2 . Secondary fragment Y 2␤ /B 3 at m/z 834.1 shows that HexNAcHep 1 PEA 2 is linked to the core Hep I residue. That HexNAc is terminal is shown by the presence of Y 3␣ fragment at m/z 1193.2. Other key fragment ion identities are shown in Fig. 4C . The derived structure is shown to the right. 1 H NMR data are shown in Table 3 . Chemical shift data were similar to those of M986 and OP1 except that ␤-Gal resonance was decreased in comparison to both of those strains. Thus, linkages and composition are confirmed to be those of the canonical LOS core with truncation such that the majority of glycomers are missing the 2ϩ , isolated at m/z 1276.3, was subjected to MS2 analysis. The derived structure and origin of fragments identified in the spectrum are shown to at the left. Gal␤1,4GlcNAc␤1,3Gal␤1,4-portion of the ␣-chain. This conclusion is consistent with monosaccharide, MALDI-TOF MS and ion-trap MS data. Structural Assignment of OP2 Plus LOS-MALDI-TOF MS analysis of OP2 plus revealed severely truncated LOS as shown in Fig. 1D . Major peaks were observed at m/z 1585.6 and 1708.7. The former is consistent with the loss of the entire oligosaccharide from Lipid A except for Hep 1 KDO 2 . The later is the same with one additional PEA residue.
Upon monosaccharide analysis neither Glc nor Gal were detected. A reduction in GlcN and an increase in molar ratio of KDO and Hep was observed. These results are in agreement with the severe truncation predicted by MALDI-TOF MS.
LC/MS ion-trap analysis revealed that a single peak was present in the extracted ion chromatogram (data not shown). Intense molecular species were detected at m/z 448.0, 877.9, 1307.9, and 1738.0 under this peak (see Fig. 2D ). Lipid A Modification-Evidence of Lipid A heterogeneity was observed in the low mass region of all strains MALDI-TOF MS spectra and that of the M986 is shown in Fig. 6 . The molecular ion for Lipid A is seen at m/z 952.6. A peak observed at 1075.6 is m/z, which is 123 atomic mass units higher in mass than Lipid A showing addition of a PEA residue. The peaks at m/z 1172.5 and 1215.6 differ by 43.1 atomic mass units, which is the mass of an ethanolamine, and these masses are consistent with KDO-Lipid A and KDO-Lipid A plus ethanolamine. A similar pattern is seen at m/z 1392.6 and 1436.0, which is consistent with KDO 2 -LipidA and KDO 2 -Lipid A plus an additional ethanolamine. These data show that the Lipid A phosphate residues can be substituted with either ethanolamine or PEA yielding PEA or pyrophosphate ethanolamine moieties, respectively, as shown in Fig. 6 above the spectrum.
Phosphoethanolamine Substitution Summary-MALDI-TOF MS analysis of M986, OP1, and OP2Ϫ deacylated LOS show that the majority of glycomers contain two PEA residues per OS with some PEA and pyrophosphate ethanolamine substitution of lipid A. Ion-trap MS and MS n of free OS from these strains confirmed that the majority of glycomers contained two PEA residues per OS chain and that these are present on Hep II (see Figs. 3 (40) , C3 substituted with Glc (6) or monosubstituted with either C3 or C6/7 PEA (5). No evidence of glycine substitution was seen in any analysis. GC/MS analysis of partially methylated partially ethylated alditol acetates revealed low abundances of 2-linked 3-phosphoheptopyranose and 2-linked 6-or 7-phosphopyranose (see supplemental Fig. S1 ). For the later it is difficult to differentiate between the 6 and 7 substitution. Peaks generated by electron impact are seen at m/z 190 and 219, and these are common to the C6 and C7 monosubstituted forms. The C7 form is expected to produce ions at m/z 350 and 58, while C6 forms give a peak at m/z 364. The diagnostic peaks indicative of the C7 form were observed but not the one for the C6 form. However, the signal intensity was low, so it is possible that both forms exist. No peaks were observed that corresponded to PEA-disubstituted Hep, likely due to poor stability of the highly substituted monosaccharide through the multistep derivatization procedure. We conclude that the majority of Hep II is PEA-disubstituted at C3 and C7 with some PEA substitution at C6 possible. A minority of Hep II is monosubstituted at only one of these positions as shown by ion-trap and GC/MS analysis.
DISCUSSION
The LOS of N. meningitidis M986 and three of its variants have been examined. The assigned structures of the largest LOS from each strain are shown in Scheme 2. The variants were selected based on low frequency spontaneous alteration in opacity as viewed in culture. In all strains except OP2ϩ the canonical core Glc 1 Hep 2 KDO 2 -Lipid A was present. OP2ϩ LOS was so severely truncated that only the Hep 1 KDO 2 -Lipid A of the core remained. The most striking difference between M986, OP1ϩ, and OP2Ϫ was seen in the ␣-chain. All of OP1ϩ LOS were missing the terminal Gal residue and all of OP2Ϫ LOS were missing the terminal Gal␤1,4GlcNAc disaccharide, although the most abundant LOS were missing Gal␤1,4GlcNAc1,3␤Gal.
Athough M986 reacts most strongly with L7 antisera, it also reacts with antisera from L2, L3, L4, and L6 (25) , suggesting that this strain's LOS contains structural motifs seen in all these immunotypes. Indeed, this study reveals this to be so. As previously discussed, M986 LOS contain an ␣-chain LNT, PEA-disubstituted Hep II, and some of its ␥-chain GlcNAc is 3-O-acetylated. Although L7 strains do not have ␤-chain GlcNAcOAc (5), L2 (3), L4 (5), and L6 (2) do. L2, L3 (4), L4, and L7 all contain LNT, although the former three are partially capped with NeuAc. L6 contains a truncated form of LNT as the terminal Gal is missing. Thus, these shared structural features may explain cross-reactivities with these antisera. Interestingly, M986 LOS does not react with L5 (25) , which also has the LNT ␣-chain. A major difference between L2, L3, L4, and L7 in comparison to L5 is that only L5 does not have Hep II PEA, and therefore it is possible that Hep II PEA is an important epitope in antibody production. Also, Hep II C3 PEA is a binding site of complement factor C4b. Antibodies to LOS bearing this substitution are bactericidal (16, 17) . Structural motifs that may mask C3 PEA epitope, such as long ␣-chain, decrease bactericidal activity suggesting that PEA exposure is crucial.
Only two phoshoethanolaminyltransferases, lgt3 and lgt6, have been found in Neisseria (41) . The former catalyzes the C3 addition, and the later has been proposed to add PEA to both C6 and C7 positions of Hep II, and in the strains studies here all of these modifications are likely present. In the current study no LOS were observed to be devoid of PEA substitution. The gene encoding the ␥-chain GlcNAc O-acetyltransferase, lot3, has been identified. In an elegant study utilizing strains containing active phosphoethanolaminyltransferases, lgt3 and lgt6, and with and without active los3 and ␤-chain glucosyltransferase lgtG evidence was presented showing that the O-acetyltransferase may interact with other elements of LOS biosynthesis to contribute to phase variation (9) . In the L2 strain NMB with an active lot3 no PEA addition was seen suggesting that O-acetylation prevented substitution with PEA. Gene disruption of los3 resulted in C6 PEA substitution of Hep II and in a lgtG los3 double knockout strain, where the ␣-chain is truncated, both C3 and C6 were PEA-substituted. This suggested that GlcNAc O-acetylation and ␣-chain length modulate PEA substitution at Hep II. Indeed, until now disubstitution of Hep II has only been reported in strains bearing a truncated ␣-chain (14) . By contrast, in the present study all strains except for OP2ϩ, which has no Hep II, had nearly stoichiometric PEA substitution of both C3 and C6/7 regardless of ␣-chain length or presumed activity of the O-acetyltransferase. Clearly, control of phase var-SCHEME 2 iation at the axis of ␣-chain length, PEA, and O-acetyl substitution is more complex than previously indicated.
Capsular polysaccharide vaccine has proven to be safe and effective for immunization against serotypes Group-A, -C, -Y, and Trp-135. Group B polysaccharide has been precluded from the above vaccines because of its poor immunogenicity in both native and conjugated forms (42, 43) . This is significant because Group-B meningococcal disease is a major contributor to the burden of meningococcal disease in the developed world (44) . For this reason there is considerable interest in the study of LOS from Group-B strains in vaccine development, and M986 and its variants should be useful in this regard. Type-B strains include immunotypes L1-L7. M986 LOS reacts with the majority of immunotypes included in this group. Here the LOS of M986 and three of its variants have been defined. These strains can now be used more effectively for immunological and vaccine studies.
